HeartStart XL+ Defibrillator/Monitor 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Philips Medical Systems 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-02-21
  • 사례 출판 날짜
    2013-02-21
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: philips heartstart xl+ defibrillator/monitor medical device manufacturer, philips healthcare issued a medical device safety alert concerning philips heartstart xl+ defibrillator/monitor (model number 861290). the affected devices were manufactured from october 2011 to january 2013, and shipped worldwide with serial numbers within the ranges below: uso1100100 – uso1100372 us61201722 – us61201924 usn1100376 – usn1100960 us71201925 – us71202048 usd1100961 – usd1101095 us81202049 – us81202168 us11201096 – us11201186 us91202169 – us91202514 us21201187 – us21201239 uso1202515 – uso1202990 us31201240 – us31201537 usn1202991 – usn1203537 us41201538 – us41201585 usd1203538 – usd1203968 us51201586 – us51201721 us11303969 – us11303972 according to philips, the philips heartstart xl+ defibrillator/monitor may fail to power on in clinical mode and instead, power on in service mode displaying an “equipment disabled: therapy” prompt, requiring the user to enter a password and perform an operational check to clear the condition. as the device will not return to clinical mode until an operational check is performed, a delay in therapy may occur. philips revealed that a software upgrade would be arranged to address the problem. meanwhile, customers are advised to continue to use the device by following any one of these three conditions (1, 2, or 3):- 1. when turning the philips heartstart xl+ defibrillator/monitor on, wait for a clinical mode screen to appear before removing ac power 2. remove ac power before turning the philips heartstart xl+ on 3. do not disconnect the heartstart xl+ defibrillator/monitor from ac power when in clinical use according to the local supplier, philips electronics hong kong ltd, the affected products have been distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 21 february 2013.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: [6 Jul 2015] Philips Medical Systems HeartStart XL+ Defibrillator/Monitor
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    DH